Investor Presentaiton
B. Preliminary Group Financial Results - Underlying Basis (continued)
B.3. Income Statement Analysis (continued)
B.3.3 Profit before tax and non-recurring items
FY2021
€ mn
FY2022
4Q2022
3Q2022
2Q2022
1Q2022
qoq+%
yoy +%
(restated¹)
Operating profit
318
198
128
81
59
50
60%
62%
Loan credit losses
(47)
(66)
(11)
(13)
(11)
(12)
-10%
-30%
Impairments of other financial
(33)
(36)
(13)
(7)
(8)
(5)
72%
-9%
and non-financial assets
Provisions for pending
litigations, regulatory and other
(11)
2
(8)
(2)
(1)
(0)
202%
matters (net of reversals)
Total loan credit losses,
(91)
(100)
(32)
(22)
(20)
(17)
42%
-8%
impairments and provisions
Profit before tax and non-
227
98
96
59
39
33
67%
133%
recurring items
Cost of risk²
0.44%
0.57%
0.42%
0.45%
0.41%
0.44%
-3 bps
-13 bps
1. Comparative information was restated following a reclassification of approximately €1 million loss relating to disposal/dissolution of subsidiaries and associates from
'Net foreign exchange gains and net gains/(losses) on financial instruments' to 'Other income'
2. Including the NPE portfolios classified as "Non-current assets and disposal groups held for sale", where relevant.
p.p. = percentage points, bps = basis points, 100 basis points (bps) = 1 percentage point
Operating profit for 4Q2022 amounted to €128 mn (compared to €81 mn for 3Q2022) and totaled €318 mn for FY2022,
up 62% yoy, driven mainly the significant increase in net interest income in the fourth quarter.
Loan credit losses for FY2022 totaled €47 mn, compared to €66 mn for FY2021 (down by 30% yoy). Loan credit losses
for 4Q2022 amounted to €11 mn compared to €13 mn for 3Q2022, down 10% qoq.
Cost of risk for FY2022 was 44 bps, compared to a cost of risk of 57 bps for FY2021, down by 13 bps reflecting strong
asset quality performance in 2022. Cost of risk for 4Q2022 accounted for 42 bps broadly flat on the prior quarter.
At 31 December 2022, the allowance for expected loan credit losses, including residual fair value adjustment on initial
recognition and credit losses on off-balance sheet exposures (please refer to Section F. 'Definitions & Explanations' for
definition) totalled €282 mn (compared to €610 mn at 30 September 2022 and €792 mn at 31 December 2021) and
accounted for 2.8% of gross loans (compared to 5.6% (2.8% pro forma for Helix 3) and 7.3% (4.5% pro forma for HFS) of
gross loans at 30 September 2022 and 31 December 2021 respectively).
Impairments of other financial and non-financial assets for FY2022 amounted to €33 mn, compared to €36 mn for
FY2021, down by 9% yoy. Impairments of other financial and non-financial assets for 4Q2022 amounted to €13 mn,
compared to €7 mn for 3Q2022, driven by higher impairments on specific, large, illiquid REMU stock properties.
Provisions for pending litigations, regulatory and other matters (net of reversals) for FY2022 amounted to €11 mn,
compared to a reversal of €2 mn for FY2021. Provisions for pending litigations, regulatory and other matters (net of
reversals) for 4Q2022 amounted to €8 mn compared to €2 mn for 3Q2022, impacted by a one-off charge of c.€5.5 mn in
relation to a revised approach on pending litigation fees.
Profit before tax and non-recurring items for FY2022 totalled €227 mn, compared to €98 mn for FY2021 (more than
doubled yoy). Profit before tax and non-recurring items for 4Q2022 amounted to €96 mn compared to €59 mn for 3Q2022
(up by 67% qoq).
222
22View entire presentation